Skip to main content
Top
Published in: Lung 1/2023

Open Access 26-01-2023 | Bronchiectasis | COUGH

Healthcare-Seeking Behaviour Due to Cough in Finnish Elderly: Too Much and Too Little

Authors: Johanna Tuulikki Kaulamo, Anne Marika Lätti, Heikki Olavi Koskela

Published in: Lung | Issue 1/2023

Login to get access

Abstract

Introduction

Cough-related healthcare-seeking has not been studied specifically in the elderly, although chronic cough is most prevalent among them. We studied the frequencies and predictors of any (≥ 1) and repeated (≥ 3) doctor’s visits due to any cough episode during the past year, and due to the current cough episode.

Methods

This was a cross-sectional email survey among a Finnish community-based elderly population. Participants with current cough and age ≥ 64 years were included in the analyses (n = 1109).

Results

The proportions of participants with ≥ 1 and ≥ 3 cough-related doctor’s visits during the past year were 25.9% and 7.1%, respectively. Repeated visitors accounted for 55.9% of the visits during the past year. These visits first increased with cough duration but decreased after 5 years. In the multivariate analysis, bronchiectasis [aOR 3.22 (CI95% 1.08–9.58)], asthma [2.62 (1.56–4.40)], chronic sputum production [1.61 (0.94–2.76)], low self-assessed health status [1.40 (1.04–1.88)] and Leicester Cough Questionnaire total score [1.34 per tertile (1.10–1.62)] predicted repeated cough-related doctor’s visits during the past year. The proportions of ≥ 1 and ≥ 3 doctor’s visits due to current cough were 31.8% and 15.5%, respectively. Among participants with current chronic cough, 60.1% had not visited a doctor.

Conclusion

A minority of participants accounted for most of the cough-related doctor’s visits during the past year, whereas most participants with chronic cough had never sought medical help for it. The heavy healthcare users were not those with the longest cough episodes. Repeated visitors due to cough were characterised by chronic phlegmy respiratory conditions, and quality-of-life impairment.
Literature
1.
go back to reference Finley CR, Chan DS, Garrison S et al (2018) What are the most common conditions in primary care? Systematic review. Can Fam Physician 64:832–840PubMedPubMedCentral Finley CR, Chan DS, Garrison S et al (2018) What are the most common conditions in primary care? Systematic review. Can Fam Physician 64:832–840PubMedPubMedCentral
15.
go back to reference Anonymous (1965) Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the medical research council by their committee on the aetiology of chronic bronchitis. Lancet 1:775–779 Anonymous (1965) Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the medical research council by their committee on the aetiology of chronic bronchitis. Lancet 1:775–779
Metadata
Title
Healthcare-Seeking Behaviour Due to Cough in Finnish Elderly: Too Much and Too Little
Authors
Johanna Tuulikki Kaulamo
Anne Marika Lätti
Heikki Olavi Koskela
Publication date
26-01-2023
Publisher
Springer US
Published in
Lung / Issue 1/2023
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-023-00595-w

Other articles of this Issue 1/2023

Lung 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine